A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)
Clinical trial NCT02993783 · TERMINATED
Trial details
- NCT number
- NCT02993783
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-28
- Primary completion
- 2018-05-09
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.